Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Humana

Humana Boosts 2025 Profit Guidance, Plans $100 Million In Strategic Investments

As the healthcare landscape evolves with new legislation and shifting demographics, Humana Inc. (NYSE:HUM) is adapting to these changes through strategic adjustments. This adaptability is reflected in their second-quarter earnings report, which exceeded analysts’ expectations despite a decline in adjusted EPS compared to last year.

Benzinga

Humana to Cut Prior Authorizations for Medicare Advantage Plans by 2026

Humana, the second-largest provider of Medicare Advantage Plans, has pledged to streamline the often frustrating Prior Authorization process.

Kiplinger

'We must do better': Fortune 100 firm Humana slashes preapproval mandates in health insurance reform push

Prior authorization is a process health insurers use to determine whether they will cover a prescription, medical procedure, or service.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Humana Moves To Cut Prior Authorization Delays, Streamline Care Approvals

Humana Inc. NYSE: HUM) on Tuesday announced accelerated efforts to approve care requests as quickly as possible and reduce the administrative burden for physicians associated with prior authorization.

Benzinga

Stocks Finish Slightly Lower on Mixed Earnings Results

The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.01%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.05%. September E-mini S&P futures (ESU25 ) fell -0.08%, and September E-mini Nasdaq futures (NQU25...

Barchart

Humana Shares Decline After Losing Medicare Bonus Payment Lawsuit: What To Know

Shares of Humana Inc. (NYSE:HUM) are trading lower Friday after the company lost a legal battle over Medicare bonus payments.

Benzinga

Stocks Pressured by Weakness in Netflix and Health Insurers

The S&P 500 Index ($SPX ) (SPY ) today down -0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.15%. September E-mini S&P futures (ESU25 ) are down -0.14%, and September E-mini Nasdaq futures (NQU25...

Barchart

Read news from The Economist, FT, and more,
with one subscription

Stock Of The Day: Is It Time To Buy Humana?

Humana Inc. (NYSE:HUM) is consolidating on Wednesday. But it may be about to reverse and rally.

Benzinga

Here's What to Expect From Humana's Next Earnings Report

Humana is scheduled to release its second-quarter results later this month, with analysts projecting single-digit earnings drop.

Barchart

8 Insurance Companies Facing Lawsuits Over Denied Senior Claims

For millions of seniors, insurance is supposed to provide peace of mind—a safety net in times of medical need, long-term care, or financial uncertainty. But...

Saving Advice

Is Humana Stock Underperforming the Dow?

Humana has underperformed the Dow over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

Breakups between health systems and Medicare Advantage plans have increased. Sometimes, patients get to leave plans, too

It's usually challenging for patients to get out of Medicare Advantage. It can be easier if hospitals leave, first.

Fortune

2 Healthcare Recession-Resistant Stocks Unaffected by Tariffs

Health insurance stocks are outperforming the benchmark indices in 2025, as these two tariff-free and recession-resistant carriers are up 16% and 54%.

MarketBeat

Earnings Preview: What to Expect From Humana's Report

Humana is expected to release its fiscal first-quarter earnings later this month, and analysts project a double-digit profit rise.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Euronews

S&P 500 rises 3.4% as some relief washes through financial markets

Stocks are rising on Wall Street and around the world to recover some of the historic losses since last week when President Donald Trump announced sharp increases in taxes on goods imported to the US.

Barchart

Is Humana Stock Underperforming the Nasdaq?

Although Humana has underperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

MarketBeat

Humana Gains Despite Medicare Advantage Losses—What’s the Catch?

Humana is the second largest health insurance provider of Medicare Advantage (MA) plans sounding the alarms of rising medical costs but will now cut 10%

Barchart

Humana Stock: Is Wall Street Bullish or Bearish?

Humana has underperformed the broader market by a large margin over the past year and analysts remain cautiously bullish on the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Kiplinger

Medicare Advantage Plans: Prior Authorization Denial Rates

Will your care be denied? Medicare Advantage insurers use prior authorization to manage utilization and lower costs. How does your plan measure up?

MarketBeat

Momentum Grows for These 3 Healthcare Stocks

As the market starts to reflect on the potential tail risks in the S&P 500, a rotation has shown itself in three stocks in the healthcare sector.

The Guardian - US

New AI tool counters health insurance denials decided by automated algorithms

Class-action lawsuits allege algorithms turn down claims in seconds and critics say reform is needed for lasting change

Barchart

Humana's Quarterly Earnings Preview: What You Need to Know

Humana is set to release its fourth-quarter results later this month, with analysts anticipating a significant drop in earnings.

Barchart

Is Humana Stock Underperforming the S&P 500?

Humana has substantially underperformed the S&P 500 over the past year and analysts remain cautiously bullish on the stock’s prospects.

Fortune

Medicare agents might not recommend the best plans this year as profits take priority

Curbing agents’ commissions may hurt beneficiaries.

Barchart

Humana Stock: Analyst Estimates & Ratings

Despite Humana underperforming the broader market over the past year, Wall Street analysts remain moderately bullish on the stock’s prospects.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Michigan

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.